HDA Media And Political Bulletin – 19 September 2016

NHS chief: We must be ‘resolute’ about ‘controversial’ cuts

19 September 2016, Chemist & Druggist, Annabelle Collins


Simon Stevens, the Chief Executive of NHS England has spoken about the value of community pharmacy in England. However he also indicated that the profession could not avoid the implementation of efficiency cuts being made across the health service. Labour MP Karin Smyth has raised concerns that the delay to pharmacy funding cuts has given the impression that the Department of Health does not have an overall plan for the future of the NHS.


September 2016 Price Concessions and NCSO

19 September 2016, PSNC


The Department of Health granted the following price concessions for September 2016:

The price concession only applies to the month that it is granted.

Drug Pack size Price concession
Amitriptyline 50mg tablets 28 £3.44
Bumetanide 1mg tablets 28 £2.20
Dapsone 50mg tablets 28 £46.19
Desmopressin 10micrograms/dose nasal spray 60 dose £25.00
Flecainide 100mg tablets 60 £12.95
Gabapentin 600mg tablets 100 £9.75
Isosorbide mononitrate 10mg tablets 56 £3.31
Isosorbide mononitrate 20mg tablets 56 £4.00
Lamotrigine 5mg dispersible tablets sugar free 28 £7.45
Metronidazole 400mg tablets 21 £8.10
Naratriptan 2.5mg tablets 6 £24.55
Nitrofurantoin 100mg tablets 28 £13.99
Nitrofurantoin 50mg tablets 28 £16.00
Ropinirole 0.5mg tablets 28 £14.00
Ropinirole 1mg tablets 84 £55.25
Valsartan 160mg capsules 28 £5.30
Valsartan 80mg capsules 28 £4.14

No endorsements are required as these prices will automatically be applied to this month’s prescriptions.

When any NCSO or price concession announcements are made, these appear on the Generic Shortages page ( and are emailed to those subscribed to this mailing list.


Parliamentary Coverage


There is no parliamentary coverage today.


Full Coverage

NHS chief: We must be ‘resolute’ about ‘controversial’ cuts

19 September 2016, Chemist & Druggist, Annabelle Collins


NHS England must be resolute about its “controversial” funding decisions, chief executive Simon Stevens has said when questioned about community pharmacy.

Speaking at a parliamentary Public Accounts Committee oral evidence session last week (September 14), Mr Stevens responded to a question from Labour MP Karin Smyth about pharmacy minister David Mowat’s announcement that details of a planned cut to pharmacy funding would be delayed.

Ms Smyth, MP for Bristol South, said: “There has been a reprieve or a delay for cuts that were in the forward budgets for next year. Community pharmacy, we read, has been saved.”

After first announcing that the planned 6% cut to pharmacy funding in England is to be delayed beyond October, the Department of Health wrote to pharmacy organisations last week (September 14) to inform them that a funding “package” for the sector will be announced in mid-October – and implemented in December.

Ms Smyth said the delay to the funding decision does not give confidence that there is an “overall plan [for the health service] that people are sticking to”.

Mr Stevens denied Ms Smyth’s suggestion that a delay to the £170 million cut to funding amounted to a “raid” by the Department of Health on the NHS. But the delay in implementing the cut is a “further budget pressure”, which he is “having to manage”, he said.

Community pharmacy is “hugely valuable”, but there are “legitimate considerations” that the NHS is spending “something like £2.8 billion” in order to “dole out £8 billion-worth of medicines”, Mr Stevens claimed.

“There are efficiencies to be made in every part of our cost structure,” he said.

“In order to deliver against the funding that we have, we are going to have to be resolute on some often quite controversial decisions,” Mr Stevens added.

Royal Pharmaceutical Society fellow and former pharmacist Steve Churton told C+D that he hopes Mr Stevens’ comments do not reflect that NHS England “fundamentally misunderstands the role and value of community pharmacy”.

Referring specifically to Mr Steven’s comment about pharmacists “doling out” medicines, Mr Churton said it “does not bode well”.

HDA Media And Political Bulletin – 19 September 2016

From Factory to Pharmacy

As part of our mission to build awareness, understanding and appreciation of the vital importance of the healthcare distribution sector, we developed an infographic explaining the availability of medicines. It identifies the factors that can impact drug supply, as well as the measures that HDA members undertake day in, day out to help mitigate the risks of patients not receiving their medicines.

See the Infographic

Apply to become a Member

Membership of the HDA guarantees your organisation:

  • Access to leading policy and industry forums of debate and discussion
  • Invitations to a range of networking industry events organised through the year, including an Annual Conference and a Business Day
  • Representation on HDA working parties, including the Members’ Liaison Group
  • A daily Political and Media Bulletin and HDA Newsletters
  • Access to HDA policy documents and all sections of the HDA website
  • Branding and marketing opportunities
Apply Now

Already a Member?